Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Retinal progenitor cells for treatment of retinitis pigmentosa

  • Post author:
  • Post published:July 12, 2025
  • Post category:

The targeted disease is retinitis pigmentosa (RP), a severe form of blindness that often runs in families, but other times arises spontaneously from genetic errors. This disease is not overly…

Continue ReadingRetinal progenitor cells for treatment of retinitis pigmentosa

Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy

  • Post author:
  • Post published:July 12, 2025
  • Post category:

Alzheimer’s disease (AD), the leading cause of dementia, results in profound loss of memory and cognitive function, and ultimately death. In the US, someone develops AD every 69 seconds and…

Continue ReadingRestoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy

Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

  • Post author:
  • Post published:July 12, 2025
  • Post category:

While current treatment strategies for high-grade glioma can yield short term benefits, their inability to eradicate the highly tumorigenic cancer stem cell population results in disease recurrence in the vast…

Continue ReadingTargeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

Heart Repair with Human Tissue Engineered Myocardium

  • Post author:
  • Post published:July 12, 2025
  • Post category:

Heart disease is the number one cause of morbidity and mortality in the US. With an estimated 1.5 million new or recurrent myocardial infarctions, the total economic burden on our…

Continue ReadingHeart Repair with Human Tissue Engineered Myocardium

Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair

  • Post author:
  • Post published:July 12, 2025
  • Post category:

An estimated 16.3 million Americans suffer from coronary heart disease. Every 25 seconds, someone has a coronary event and every minute, someone dies from one. Treatment for coronary heart disease…

Continue ReadingExtracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair

Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury

  • Post author:
  • Post published:July 12, 2025
  • Post category:

We aim to develop a novel stem cell treatment for spinal cord injury (SCI) that is substantially more potent than previous stem cell treatments. By combining grafts of neural stem…

Continue ReadingFunctional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury

Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis

  • Post author:
  • Post published:July 12, 2025
  • Post category:

Multiple sclerosis (MS) is an autoimmune disease in which the myelin sheath that insulates neurons is destroyed, resulting in loss of proper neuronal function. Existing treatments for MS are based…

Continue ReadingTargeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis

Regeneration of Functional Human Corneal Epithelial Progenitor Cells

  • Post author:
  • Post published:July 12, 2025
  • Post category:

Over 3.2 million people worldwide are bilateral blind from corneal diseases. Limbal stem cell deficiency (LSCD) has been recognized as a major cause, either primary or secondary, of significant visual…

Continue ReadingRegeneration of Functional Human Corneal Epithelial Progenitor Cells

Liver Cell Transplantation

  • Post author:
  • Post published:July 12, 2025
  • Post category:

Because there is still considerable morbidity and mortality associated with the process of whole liver transplantation, and because more than a thousand people die each year while on the liver…

Continue ReadingLiver Cell Transplantation

Development of RNA-based approaches to stem cell gene therapy for HIV

  • Post author:
  • Post published:July 12, 2025
  • Post category:

Despite significant advances in treatment and prevention programs, HIV infection with progression to Acquired Immunodeficiency Syndrome (AIDS) is still prevalent in California. The CDC Estimates >56,000 new cases of HIV…

Continue ReadingDevelopment of RNA-based approaches to stem cell gene therapy for HIV
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us